

Clinical genetics
Clinical pathology and cytology
Clinical immunology and transfusion medicine
Does it matter which part of the brain a tumor originates from? Is it important to determine how young a patient was when the cancer started? IGP researcher Fredrik Swartling has in collaboration with researchers from USA, Canada and England shown that childhood brain tumors preserve certain characteristics that are present in the normal cell from which they originated.
Chronic lymphocytic leukemia is a tumor disease with varying progression. Many patients can live for a long time with their disease while others rapidly deteriorate. Researchers in the groups of Richard Rosenquist and Ulf Gyllensten have used a new sequencing technique to study and compare genetic alterations in groups of patients with different prognosis. The results showed that the technique can be used to study chronic lymphocytic leukemia in ways previously not possible.
The fatty acids omega-3 and omega-6 are essential for the development and function of the human brain. In a recent study led by researchers at IGP it was found that during evolution humans have been genetically adapted to more efficiently synthesize omega-3 and omega-6 from fatty acids in vegetable oils. This adaptation would have been an advantage in situations with a limited supply of food with omega-3 and omega-6. Today, it can instead be associated with an increased risk for coronary artery disease
Gå till RSS
Bo Nilsson has received a grant of 3.6 million SEK from the insurance company AFA Försäkring, for a project focusing on how nano particles affect the immune response.
Ulf Gyllensten has, together with Joakim Lundeberg at KTH, been awarded a grant of 57.8 million SEK from the Knut and Alice Wallenberg Foundation. The grant will be used for genome sequencing equipment at SciLifeLab’s sequencing platforms in Uppsala and Stockholm.
Niklas Dahl has received the Uppsala County Council research prize for his research on genetic alterations associated with heritable diseases.